A MULTICENTER, PROSPECTIVE, OPEN-LABEL STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF GADOQUATRANE IN PEDIATRIC PARTICIPANTS (FROM BIRTH TO <18 YEARS) UNDERGOING CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING (CE-MRI).

Registry ID

21196

Source registry

HEALTH_CANADA

Status

Closed

Study type

INTERVENTIONAL

Sponsor

BAYER INC

Start date

2024-03-08

Completion date

2024-11-21

Last update

2023-06-14

Conditions

• MRI IMAGING

Related clinical trials

• THE CANADIAN LUNG OUTCOMES IN USERS OF VAPING DEVICES (CLOUD) STUDY
• DEVELOPMENT OF HARDWARE AND SOFTWARE FOR PULMONARY MAGNETIC RESONANCE IMAGING USING INHALED TRACER GASES
• CANADIAN LONGITUDINAL STUDY OF LUNG STRUCTURE AND FUNCTION IN CANNABIS SMOKERS (CANUCK)
• A MECHANISTIC PILOT OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF BENRALIZUMAB ON AIRWAY FUNCTION AND INFLAMMATION IN PATIENTS WITH SEVERE, POORLY-CONTROLLED EOSINOPHILIC ASTHMA USING INHALED HYPERPOLARIZED 129XE MRI (AERFLO)
• NON-ISOTOPE BASED IMAGING MODALITIES VS 99MTC SPECT MYOCARDIAL PERFUSION IMAGING (MPI) TO DETECT MYOCARDIAL ISCHEMIA IN PATIENTS AT HIGH RISK FOR ISCHEMIC CARDIOVASCULAR EVENTS
• STRUCTURE AND FUNCTION MRI OF ASTHMA

View on source registry